Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
BRCA2 positive
i
Other names:
BRCA2, BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, Breast cancer 2, early onset
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
675
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
BRCA2 mutation (200)
BRCA wild-type (19)
BRCA1 mutation + BRCA2 mutation (4)
BRCA2 A902fs*2 (3)
BRCA2 mutation + CHEK2 mutation (2)
BRCA2 mutation + TP53 mutation (2)
BRCA2 rearrangement (2)
APC mutation + BRCA2 mutation (1)
BRCA2 1153insT (1)
BRCA2 5396insC (1)
BRCA2 I2315T (1)
BRCA2 L557* (1)
BRCA2 N255fs + D252fs (1)
BRCA2 Y1655* + TP53 mutation (1)
BRCA2 biallelic inactivation (1)
BRCA2 mutation + ATM mutation (1)
BRCA2 mutation + CDK12 mutation (1)
BRCA2 mutation + SPOP mutation (1)
BRCA2 mutation + TP53 D816Y (1)
CHEK2 mutation + ATM mutation + BRCA2 mutation (1)
EGFR exon 19 deletion + BRCA2 mutation (1)
BRCA2 E260fs (0)
BRCA2 N255_R259delinsIK (0)
BRCA2 N255fs (0)
BRCA2 N255fs + BRCA2 N255_R259delinsIK + BRCA2 E260fs (0)
BRCA2 mutation (200)
BRCA wild-type (19)
BRCA1 mutation + BRCA2 mutation (4)
BRCA2 A902fs*2 (3)
BRCA2 mutation + CHEK2 mutation (2)
BRCA2 mutation + TP53 mutation (2)
BRCA2 rearrangement (2)
APC mutation + BRCA2 mutation (1)
BRCA2 1153insT (1)
BRCA2 5396insC (1)
BRCA2 I2315T (1)
BRCA2 L557* (1)
BRCA2 N255fs + D252fs (1)
BRCA2 Y1655* + TP53 mutation (1)
BRCA2 biallelic inactivation (1)
BRCA2 mutation + ATM mutation (1)
BRCA2 mutation + CDK12 mutation (1)
BRCA2 mutation + SPOP mutation (1)
BRCA2 mutation + TP53 D816Y (1)
CHEK2 mutation + ATM mutation + BRCA2 mutation (1)
EGFR exon 19 deletion + BRCA2 mutation (1)
BRCA2 E260fs (0)
BRCA2 N255_R259delinsIK (0)
BRCA2 N255fs (0)
BRCA2 N255fs + BRCA2 N255_R259delinsIK + BRCA2 E260fs (0)
›
Associations
(1)
News
Trials
Search handles
Search handles
Filter by
Latest
11ms
After being diagnosed with breast and pancreatic cancer, Betty Dicker, a BRCA2 positive patient of Dr. Diane M. Simeone (@MadameSimeone) and Dr. Paul Oberstein (@MD_Oberstein), shares her survivorship journey with @ASCOPost. #ASCO23 Read her story: https://t.co/4qFe7Hct65 (@Perlmutter_CC)
11 months ago
Clinical
|
BRCA2 (Breast cancer 2, early onset)
|
BRCA2 positive
over2years
@JenniferLitton discusses the rationale for examining neoadjuvant talazoparib in patients with BRCA1/2-positive, early HER2-negative breast cancer, safety and efficacy results from NEOTALA, and next steps for research. @MDAndersonNews #bcsm https://t.co/6s87V37LgT (@OncLive)
over 2 years ago
Clinical
|
HER-2 (Human epidermal growth factor receptor 2) • BRCA1 (Breast cancer 1, early onset) • BRCA2 (Breast cancer 2, early onset)
|
HER-2 negative • BRCA1 positive • BRCA2 positive
|
Talzenna (talazoparib)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login